vs

Side-by-side financial comparison of ALEXANDERS INC (ALX) and Inogen Inc (INGN). Click either name above to swap in a different company.

Inogen Inc is the larger business by last-quarter revenue ($68.6M vs $53.3M, roughly 1.3× ALEXANDERS INC). On growth, Inogen Inc posted the faster year-over-year revenue change (3.4% vs -4.7%). Over the past eight quarters, Inogen Inc's revenue compounded faster (4.2% CAGR vs -6.9%).

Alexander's, Inc. is a real estate investment trust that owns 7 properties in New York metropolitan area, including 731 Lexington Avenue, the headquarters of Bloomberg L.P. It is controlled by Vornado Realty Trust. It was founded by George Farkas and Louis Schwadron in 1928.

Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.

ALX vs INGN — Head-to-Head

Bigger by revenue
INGN
INGN
1.3× larger
INGN
$68.6M
$53.3M
ALX
Growing faster (revenue YoY)
INGN
INGN
+8.2% gap
INGN
3.4%
-4.7%
ALX
Faster 2-yr revenue CAGR
INGN
INGN
Annualised
INGN
4.2%
-6.9%
ALX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ALX
ALX
INGN
INGN
Revenue
$53.3M
$68.6M
Net Profit
Gross Margin
51.4%
Operating Margin
-13.6%
Net Margin
Revenue YoY
-4.7%
3.4%
Net Profit YoY
EPS (diluted)
$0.75
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALX
ALX
INGN
INGN
Q4 25
$53.3M
$68.6M
Q3 25
$53.4M
$79.1M
Q2 25
$51.6M
$79.2M
Q1 25
$54.9M
$68.5M
Q4 24
$55.9M
$66.3M
Q3 24
$55.7M
$74.9M
Q2 24
$53.4M
$74.4M
Q1 24
$61.4M
$63.1M
Net Profit
ALX
ALX
INGN
INGN
Q4 25
Q3 25
$6.0M
$-5.3M
Q2 25
$6.1M
$-4.2M
Q1 25
$12.3M
$-6.2M
Q4 24
Q3 24
$6.7M
$-6.0M
Q2 24
$8.4M
$-5.6M
Q1 24
$16.1M
$-14.6M
Gross Margin
ALX
ALX
INGN
INGN
Q4 25
51.4%
Q3 25
52.2%
Q2 25
52.2%
Q1 25
53.1%
Q4 24
54.7%
Q3 24
55.2%
Q2 24
57.4%
Q1 24
54.5%
Operating Margin
ALX
ALX
INGN
INGN
Q4 25
-13.6%
Q3 25
-9.0%
Q2 25
-7.7%
Q1 25
-11.2%
Q4 24
-17.2%
Q3 24
-10.4%
Q2 24
-9.5%
Q1 24
-25.8%
Net Margin
ALX
ALX
INGN
INGN
Q4 25
Q3 25
11.2%
-6.7%
Q2 25
11.9%
-5.2%
Q1 25
22.4%
-9.0%
Q4 24
Q3 24
12.0%
-8.0%
Q2 24
15.7%
-7.5%
Q1 24
26.2%
-23.1%
EPS (diluted)
ALX
ALX
INGN
INGN
Q4 25
$0.75
$-0.26
Q3 25
$1.16
$-0.20
Q2 25
$1.19
$-0.15
Q1 25
$2.40
$-0.25
Q4 24
$2.39
$-0.41
Q3 24
$1.30
$-0.25
Q2 24
$1.63
$-0.24
Q1 24
$3.14
$-0.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALX
ALX
INGN
INGN
Cash + ST InvestmentsLiquidity on hand
$128.2M
$103.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$109.2M
$192.2M
Total Assets
$1.1B
$298.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALX
ALX
INGN
INGN
Q4 25
$128.2M
$103.7M
Q3 25
$286.1M
$106.5M
Q2 25
$313.0M
$103.7M
Q1 25
$319.9M
$118.9M
Q4 24
$338.5M
$113.8M
Q3 24
$354.8M
$105.7M
Q2 24
$410.9M
$97.9M
Q1 24
$526.3M
$107.4M
Stockholders' Equity
ALX
ALX
INGN
INGN
Q4 25
$109.2M
$192.2M
Q3 25
$128.3M
$197.2M
Q2 25
$145.4M
$199.5M
Q1 25
$163.1M
$198.0M
Q4 24
$176.9M
$173.9M
Q3 24
$190.7M
$185.4M
Q2 24
$212.5M
$187.6M
Q1 24
$230.1M
$191.9M
Total Assets
ALX
ALX
INGN
INGN
Q4 25
$1.1B
$298.6M
Q3 25
$1.3B
$307.0M
Q2 25
$1.3B
$312.0M
Q1 25
$1.3B
$308.4M
Q4 24
$1.3B
$296.2M
Q3 24
$1.4B
$306.2M
Q2 24
$1.5B
$308.9M
Q1 24
$1.4B
$315.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALX
ALX
INGN
INGN
Operating Cash FlowLast quarter
$73.4M
$-943.0K
Free Cash FlowOCF − Capex
$-1.9M
FCF MarginFCF / Revenue
-2.8%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-13.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALX
ALX
INGN
INGN
Q4 25
$73.4M
$-943.0K
Q3 25
$-9.3M
$2.2M
Q2 25
$43.6M
$4.3M
Q1 25
$15.7M
$-16.8M
Q4 24
$54.1M
$-3.0M
Q3 24
$-5.0M
$7.0M
Q2 24
$11.5M
$6.7M
Q1 24
$16.8M
$-4.7M
Free Cash Flow
ALX
ALX
INGN
INGN
Q4 25
$-1.9M
Q3 25
$1.6M
Q2 25
$3.7M
Q1 25
$-17.1M
Q4 24
$-3.3M
Q3 24
$5.3M
Q2 24
$6.6M
Q1 24
$-6.1M
FCF Margin
ALX
ALX
INGN
INGN
Q4 25
-2.8%
Q3 25
2.0%
Q2 25
4.6%
Q1 25
-24.9%
Q4 24
-5.0%
Q3 24
7.1%
Q2 24
8.9%
Q1 24
-9.6%
Capex Intensity
ALX
ALX
INGN
INGN
Q4 25
1.4%
Q3 25
0.7%
Q2 25
0.9%
Q1 25
0.4%
Q4 24
0.5%
Q3 24
2.2%
Q2 24
0.1%
Q1 24
2.1%
Cash Conversion
ALX
ALX
INGN
INGN
Q4 25
Q3 25
-1.55×
Q2 25
7.12×
Q1 25
1.28×
Q4 24
Q3 24
-0.75×
Q2 24
1.37×
Q1 24
1.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALX
ALX

Segment breakdown not available.

INGN
INGN

Other$36.1M53%
Non Us$32.5M47%

Related Comparisons